Status:
UNKNOWN
Long Term Tapering or Standard Steroids for Nephrotic Syndrome
Lead Sponsor:
Institute of Child Health
Conditions:
Nephrotic Syndrome
Eligibility:
All Genders
1-15 years
Phase:
PHASE4
Brief Summary
Parallel group double blind randomised in patients with first episode corticosteroid sensitive nephrotic syndrome comparing time to relapse and adverse effects associated with a longer tapering steroi...
Eligibility Criteria
Inclusion
- newly presenting nephrotic syndrome, urine albumin/protein creatinine ratio \>200mg/mmol on early morning urine sample, hypoalbuminemia (\<25g/L)
Exclusion
- prior treatment with steroids or cytotoxic agents underlying systemic disorder or exposure to agents known to be associated with newly presenting steroid sensitive nephrotic syndrome
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00308321
Start Date
September 1 2003
End Date
October 1 2008
Last Update
November 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Child Health
London, United Kingdom, WC1N 1EH